# Safety and Efficacy Study of Extracorporeal Shockwave Therapy in the Treatment of Patients With Resistant Hypertension

> **NCT02042066** · PHASE1 · UNKNOWN · sponsor: **Medispec** · enrollment: 10 (estimated)

## Conditions studied

- Hypertension, Resistant to Conventional Therapy

## Interventions

- **DEVICE:** Omnispec model Vascuspec

## Key facts

- **NCT ID:** NCT02042066
- **Lead sponsor:** Medispec
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2016-01
- **Final completion:** —
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2014-01-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02042066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02042066, "Safety and Efficacy Study of Extracorporeal Shockwave Therapy in the Treatment of Patients With Resistant Hypertension". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT02042066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*